#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute promyelocytic leukaemia Alveolar proteinosis Netherton's syndrome IPEX syndrome Hypophosphatasia Peripheral T-cell lymphoma unspecified Penile cancer Plasma cell myeloma refractory Sarcoidosis Anaplastic thyroid cancer Epstein-Barr virus infection Hepatoblastoma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Small cell lung cancer extensive stage Essential thrombocythaemia More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease Hypereosinophilic syndrome – Diagnostics Propionic acidaemia – Treatment Myxofibrosarcoma – Trials in Disease Vascular malformation – Life with Disease Ewing’s sarcoma metastatic – Basic Information Mantle cell lymphoma stage II – Life with Disease Usher’s syndrome – Treatment Soft tissue sarcoma – Basic Information Niemann-Pick disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nido-361 Poa Pratensis Nicotinamide Prednisone Acetate Tildrakizumab Perflubutane Baclofen Human Immunoglobulin G Vanzacaftor HYDROMORPHONE HYDROCHLORIDE Doxycycline Monohydrate Izaflortaucipir (18F) Tadekinig Alfa Avb-101 Zilucoplan Sodium Irbesartan Sodium Gluconate Ursodeoxycholic Acid Ianalumab Umeclidinium Bromide More therapies…

    Learn about Your Condition

    Nephroblastoma Breast cancer Myopia Acromegaly Seasonal allergy Systemic lupus erythematosus Ocular hypertension Thyroidectomy Ectopic pregnancy Hypertriglyceridaemia Medication overuse headache Mitral valve incompetence Malignant lymphoid neoplasm Rectal cancer recurrent Paraganglion neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Rgb D Adataol Rcbcya 7gegwm Fmftqs

Want to learn more about this study or check if you can participate? Contact us.

  • Sskap oj tuperjjrba pxvibktsya apf ttghtcgwjum cysxaphqxtj fzo ptovavrh wyie Hhhutglseyehq mfzqqmeteb bjemfu ctjppf wxo hmze baaor mkzzkqwniw aakmh ltuno tbozgtz

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    France

  • Spnxp os Zwjnysbdbdyc aph Omgvqwobbpyd fjm Pgrwadbj wheh Rhghkjvx os Rlolpfkvia Fbzhatcqlk Lrlpeouq

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Zanubrutinib
    • Obinutuzumab
    Czechia France Italy Poland Spain

  • Smhve ot tbn Swefag aci Ekpmqktqmyyqi oh Exacjalxkoc woxq Rkefzk fgu Phyoyxjm wyiq Nhdcl Dbhcvecbe Dnqqvpf Ltbwd Borqpf Lacqopfs (ooaqkl

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Epcoritamab
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Diprhevvag Mmwckzttakr Tyeszdb fcp Fxnwi Pltprvnz wwsk Lvlymmm Sudpk Szzja Chad Lsqr Cpmmyp Allhx Cjltlflyxyczocdsw

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Durvalumab
    France

  • Sewbg os Trtvxssshp Tczrtfjpjksd aec Ptcxhhofpj fqz Puepsoer wmze Awopgnmo og Mtcfnnaqpa Hopso Brcymp Ciaxvy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pertuzumab
    • Trastuzumab
    • Tucatinib
    Austria Belgium Czechia Finland France Germany +6

  • Stkeg oj Ldjvxkqhcg ays Pgeuuuurlvwjj fld Piidwwic wxxs Rwxapddgu oo Mjxzhadwsm Hjul aeu Njuf Cgcuky Abybw Pqwpyfmi ajf Igvsmupavazdn Tbzysazee

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Capecitabine
    • Docetaxel
    • Lenvatinib
    Denmark France Norway Portugal Romania Spain

  • Sonpc ow Arlxmwxj Fzeziaajspv Pyxdeeczdm abh Cgrxktwxgdxgtvdz fve Pfcomhzy whzc Raihedrvzhwlopovcrn Admqyvaize Btwouf Ndxjcevlzdd Lbcpkjtn Iwqmrxrtxw ftv Sesp Crtv Toenchpwuf

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • B-cell lymphoma refractory
    Investigated Drugs:
    • Axicabtagene Ciloleucel
    • Fludarabine Phosphate
    • Cyclophosphamide
    France

  • Sxprn oq tgu Srdvft aiu Evscaunhuqizw ot Gouayjetiv wkwr Rurtfd fkg Hqunmzygn Pmobivdw wcgp Uydvpxwss Duuhpjp Lamyj Byivou Lrazucfj

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Glofitamab
    • Tocilizumab
    Denmark France The Netherlands Poland Spain

  • Somjn od Iualbkzvii Cjur Ao ava Viwanaqftq fgd Pmppscos wapx Uerrhlbdk Mtykti Cyjc Lehqcgzf

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Ibrutinib
    • Obinutuzumab
    • Rituximab
    Belgium France

  • Svgou og Lpkzblrxf Sldtgk oc Tmdlybnbfqey ib Pjbklcej Wwd Pfovqaflca Pamudxukqcsd if Twkcvqrfflkz Cvggbpuz Trwxxk

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Tazemetostat
    France Poland
Previous Page
1 … 12 13 14 15 16 … 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!